ABC NEWS:

Trump touts saliva coronavirus tests after FDA emergency authorization

Scientist behind saliva test breakthrough sees bridge to nationwide coronavirus screening

In a Rose Garden briefing, Tuesday President Donald Trump touted a potential new way of testing for the novel coronavirus could be safer for suspected coronavirus patients and health care workers and help alleviate the backlog in hard-hit cities — spit.

The Food and Drug Administration gave emergency authorization Friday for a testing method developed by a Rutgers University lab that, instead of relying on swabs that reach deep into the nasal cavity, is designed to check for evidence of the virus in a patient’s saliva.

“I call it innovation under pressure,” Trump said. “The tests can be self-administered by patients in health care settings, which will reduce exposure for medical workers and save personal protective equipment.”

Rutgers said the saliva tests are already being made available to the large New Jersey health care system RWJBarnabas and at a number of New Jersey hospitals and facilities. A drive-thru testing facility utilizing this new method is also planned this week in Edison, New Jersey.

Though the tests are only now ramping up, already several companies have begun working on manufacturing and selling versions of them, including the start-up Vault Health, a New York-based men’s health company.

“This is not an at-home test,” Hahn said of the government-authorized method. “This still has to be performed with a provider, but it does provide great advantages moving forward and expands the opportunities for testing.”

Abdelmalek said concerns about self-administered tests stem in part from the worry that the patient could make an error that leads to an incorrect outcome — and waste valuable testing resources in the process.

Spectrum Solutions Saliva Collection Kit COVID-19 Testing

© Spectrum Solutions™ | Photo Credit: Leslie Titus Bryant

Scientist behind saliva test breakthrough sees bridge to nationwide coronavirus screening

In a Rose Garden briefing, Tuesday President Donald Trump touted a potential new way of testing for the novel coronavirus could be safer for suspected coronavirus patients and health care workers and help alleviate the backlog in hard-hit cities — spit.

The Food and Drug Administration gave emergency authorization Friday for a testing method developed by a Rutgers University lab that, instead of relying on swabs that reach deep into the nasal cavity, is designed to check for evidence of the virus in a patient’s saliva.

“I call it innovation under pressure,” Trump said. “The tests can be self-administered by patients in health care settings, which will reduce exposure for medical workers and save personal protective equipment.”

Rutgers said the saliva tests are already being made available to the large New Jersey health care system RWJBarnabas and at a number of New Jersey hospitals and facilities. A drive-thru testing facility utilizing this new method is also planned this week in Edison, New Jersey.

Though the tests are only now ramping up, already several companies have begun working on manufacturing and selling versions of them, including the start-up Vault Health, a New York-based men’s health company.

“This is not an at-home test,” Hahn said of the government-authorized method. “This still has to be performed with a provider, but it does provide great advantages moving forward and expands the opportunities for testing.”

Abdelmalek said concerns about self-administered tests stem in part from the worry that the patient could make an error that leads to an incorrect outcome — and waste valuable testing resources in the process.

Spectrum Solutions Saliva Collection Kit COVID-19 Testing

© Spectrum Solutions™ | Photo Credit: Leslie Titus Bryant

ABC News- Trump touts saliva coronavirus tests after FDA emergency authorization

Spectrum in the News

Spectrum in the News

About the Product

Innovative Engineering SDNA-1000

Open-blister-pack-spectrum-saliva-dna-collection-device

Spectrum Solutions has manufactured over 20 million Saliva Collection devices for distribution worldwide. Spectrum’s technically superior  SDNA-1000 saliva collection device was engineered to lead the saliva collection industry in molecular diagnostics and clinical research applications.

  • First saliva collection device to receive EUA authorization for COVID-19 testing
  • First saliva collection device FDA authorized for at-home sample collection
  • Only painless biosample collection option for COVID-19 testing
  • Engineered to reduce self-collection error
  • Delivers consistent high-quality, high-yield biosamples
  • 100% inactivation of the live virus
  • 100% bacteriostatic
  • Saliva collection system mitigates all risk of infection to those individuals administering the test
  • SDNA-1000 delivers over a 90% reduction in PPE usage compared to current swab collections for COVID-19 testing
  • Single device preserves both DNA and fragile viral RNA transcripts
  • Stabilizes and extends biosample viability over two weeks at room temperature for shipping and transport needs

The inactivation of the virus in the SDNA-1000 saliva collection device creates the most robust and safest biomaterial collection approach for the detection of COVID-19 infection.

Questions? Let’s Connect